Safety profile and clinical activity of sifalimumab, a fully human anti-interferon monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
収録刊行物
-
- Annals of the Rheumatic Diseases
-
Annals of the Rheumatic Diseases 70 (11), 1905-1913, 2011-07-27
BMJ